REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $325,798 | +10.3% | 26,970 | -3.4% | 0.00% | – |
| Q2 2023 | $295,404 | +35.1% | 27,921 | +25.6% | 0.00% | – |
| Q1 2023 | $218,674 | -30.2% | 22,223 | +4.4% | 0.00% | – |
| Q4 2022 | $313,220 | +78.0% | 21,293 | +47.7% | 0.00% | – |
| Q3 2022 | $176,000 | -12.9% | 14,420 | +0.1% | 0.00% | – |
| Q2 2022 | $202,000 | +15.4% | 14,412 | +18.0% | 0.00% | – |
| Q1 2022 | $175,000 | -12.9% | 12,209 | +89.2% | 0.00% | – |
| Q2 2021 | $201,000 | -23.0% | 6,454 | -24.2% | 0.00% | – |
| Q1 2021 | $261,000 | – | 8,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,560,703 | $78,588,000 | 15.73% |
| MPM ASSET MANAGEMENT LLC | 2,603,089 | $79,889,000 | 15.43% |
| MPM BioImpact LLC | 2,069,749 | $63,521,000 | 7.98% |
| BVF INC/IL | 3,722,398 | $114,240,000 | 4.28% |
| StepStone Group LP | 8,721 | $268,000 | 4.12% |
| Logos Global Management LP | 900,000 | $27,621,000 | 2.70% |
| Redmile Group, LLC | 2,665,496 | $81,804,000 | 1.15% |
| Orbimed Advisors | 3,426,325 | $105,154,000 | 0.98% |
| Soleus Capital Management, L.P. | 133,324 | $4,092,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 248,100 | $7,614,000 | 0.58% |